<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38572142</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2472-0712</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>Exploratory research and hypothesis in medicine</Title><ISOAbbreviation>Explor Res Hypothesis Med</ISOAbbreviation></Journal><ArticleTitle>Challenges and Opportunities Associated with Lifting the Zero COVID-19 Policy in China.</ArticleTitle><Pagination><StartPage>71</StartPage><EndPage>75</EndPage><MedlinePgn>71-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14218/erhm.2023.00002</ELocationID><Abstract><AbstractText>Chinese government lifted its "Zero COVID-19" policy in December 2022. The estimated COVDI-19 new cases and deaths after the policy change are 167-279 million (about 12.0% to 20.1% of the Chinese population) and 0.68-2.1 million, respectively. Recent data also revealed continuous drops in fertility rate and historically lowest growth in gross domestic production in China. Thus, balancing COVID-19 control and economic recovery in China is of paramount importance yet very difficult. Supply chain disruption, essential service reduction and shortage of intensive care units have been discussed as the challenges associated with lifting "Zero COVID-19" policy. The additional challenges may include triple epidemic of COVID-19, respiratory syncytial virus and influenza, mental health issues of healthcare providers, care givers and patients, impact on human mobility, lack of robust genomic and epidemiological data and long COVID-19. However, the policy-associated opportunities and other challenges are largely untouched, but warrant attention of and prompt reactions by the policy makers, healthcare providers, public health officials and other stakeholders. The associated benefits are quick reach of herd immunity, boost of economy and businesses activities and increase in social activities. At this moment, we must embrace the policy change, effectively mitigate its associated problems and timely and effectively maximize its associated benefits.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lanjing</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5436-887X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Princeton Medical Center, Plainsboro, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R37 CA277812</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Explor Res Hypothesis Med</MedlineTA><NlmUniqueID>101712959</NlmUniqueID><ISSNLinking>2472-0712</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Influenza</Keyword><Keyword MajorTopicYN="N">Outbreak</Keyword><Keyword MajorTopicYN="N">Respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">Tripledemic</Keyword></KeywordList><CoiStatement>Conflict of interest ZC is an employee and owns stocks of Bristol Myers Squibb, Co. The spouse of LZ is an employee and owns stocks of Bristol Myers Squibb, Co. The opinions expressed in the article are solely those of the authors, and not of their affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>4</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38572142</ArticleId><ArticleId IdType="mid">NIHMS1881356</ArticleId><ArticleId IdType="pmc">PMC10989839</ArticleId><ArticleId IdType="doi">10.14218/erhm.2023.00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yuan S. Zero COVID in China: what next? Lancet 2022;399(10338): 1856&#x2013;1857. doi:10.1016/S0140-6736(22)00873-X, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00873-X</ArticleId><ArticleId IdType="pmc">PMC9098203</ArticleId><ArticleId IdType="pubmed">35569453</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. China&#x2019;s zero-COVID strategy: what happens next? Nature 2022;602(7895):15&#x2013;16. doi:10.1038/d41586-022-00191-7, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00191-7</ArticleId><ArticleId IdType="pubmed">35087249</ArticleId></ArticleIdList></Reference><Reference><Citation>Farge E. China&#x2019;s COVID spike not due to lifting of restrictions, WHO director say. Available from: https://www.reuters.com/world/china/chinas-covid-spike-not-due-lifting-restrictions-who-director-2022-12-14/.
Accessed January 13, 2023.</Citation></Reference><Reference><Citation>Woo R, Pollard MQ. Beijing drops COVID testing burden as wider easing beckons. Available from: https://www.reuters.com/world/china/chinese-capital-prepares-life-again-lockdowns-lift-across-country-2022-12-06/.
Accessed January 15, 2023.</Citation></Reference><Reference><Citation>Cheng S. China Scraps Most Covid Testing, Quarantine Requirements in Policy Pivot. Available from: https://www.wsj.com/articles/chinascraps-most-testing-quarantine-requirements-in-covid-19-policypivot-11670398522.
Accessed January 15, 2023.</Citation></Reference><Reference><Citation>Huang Y. The Reckoning Ahead for China&#x2019;s Zero-Covid Policy. Available from: https://www.wsj.com/articles/the-reckoning-ahead-for-chinas-zero-covid-policy-11671721521.
Accessed January 15, 2023.</Citation></Reference><Reference><Citation>Liu Q, Leng C, Yu S, McMorrow R. China estimates 250mn people have caught Covid in 20 days. Available from: https://www.ft.com/content/1fb6044a-3050-44d8-b715-80c18ca5c9ab.
Acessed January 16, 2023.</Citation></Reference><Reference><Citation>Burki T. Moving away from zero COVID in China. Lancet Respir Med 2023;11(2):132. doi:10.1016/S2213-2600(22)00508-2, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00508-2</ArticleId><ArticleId IdType="pmc">PMC9757876</ArticleId><ArticleId IdType="pubmed">36535298</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuters. Factbox: How many people might die, and why, under relaxed China COVID curb. Available from: https://www.reuters.com/world/china/how-many-people-might-die-why-if-china-loosens-covid-restrictions-2022-12-03/.
Aessed January 15, 2023.</Citation></Reference><Reference><Citation>Cowling B. The impact of ending &#x2018;zero COVID&#x2019; in China. Nat Med 2023;29(2):302. doi:10.1038/d41591-023-00001-1, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41591-023-00001-1</ArticleId><ArticleId IdType="pubmed">36604517</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanne JH. US faces triple epidemic of flu, RSV, and covid. BMJ 2022;379:o2681. doi:10.1136/bmj.o2681, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o2681</ArticleId><ArticleId IdType="pubmed">36343961</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamm S. Flu, RSV and Covid Drive Demand for Children&#x2019;s Pain Relievers and Fever Reducers. Available from: https://www.wsj.com/articles/flu-rsv-and-covid-drive-demand-for-childrens-pain-relieversand-fever-reducers-11671517354.
Accessed Febrarury 28, 2023.</Citation></Reference><Reference><Citation>Feng Z, Xu B, Zhong L, Chen J, Deng J, Luo Z, et al. A multicentre study on the incidence of respiratory viruses in children with community-acquired pneumonia requiring hospitalization in the setting of the zero-COVID policy in China. Arch Virol 2023;168(2):64. doi:10.1007/s00705-023-05698-6, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-023-05698-6</ArticleId><ArticleId IdType="pmc">PMC9839207</ArticleId><ArticleId IdType="pubmed">36639581</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang ML, Xu YP, Wu H, Zhu RN, Sun Y, Chen DM, et al. Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China. J Med Virol 2023;95(1):e28411. doi:10.1002/jmv.28411, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28411</ArticleId><ArticleId IdType="pmc">PMC9878212</ArticleId><ArticleId IdType="pubmed">36524893</ArticleId></ArticleIdList></Reference><Reference><Citation>National Immunization Advisory Committee (NIAC), Technical Working Group (TWG), Influenza Vaccination TWG. Technical guidelines for seasonal influenza vaccination in China (2022&#x2013;2023). Zhonghua Liu Xing Bing Xue Za Zhi 2022;43(10):1515&#x2013;1544. doi:10.3760/cma.j.cn112338-20220825-00734, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112338-20220825-00734</ArticleId><ArticleId IdType="pubmed">36456484</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche N, Crichton ML, Goeminne PC, Cao B, Humbert M, Shteinberg M, et al. Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J 2022;60(2):2200803. doi:10.1183/13993003.00803-2022, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00803-2022</ArticleId><ArticleId IdType="pmc">PMC9363848</ArticleId><ArticleId IdType="pubmed">35710264</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo L, Zhou Y, Li S, Ning Y, Zeng L, Liu Z, et al. Burnout and Its Relationship With Depressive Symptoms in Medical Staff During the COVID-19 Epidemic in China. Front Psychol 2021;12:616369. doi:10.3389/fpsyg.2021.616369, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.616369</ArticleId><ArticleId IdType="pmc">PMC7969997</ArticleId><ArticleId IdType="pubmed">33746836</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Wang J, Luo C, Hu S, Lin X, Anderson AE, et al. A Comparison of Burnout Frequency Among Oncology Physicians and Nurses Working on the Frontline and Usual Wards During the COVID-19 Epidemic in Wuhan, China. J Pain Symptom Manage 2020;60(1):e60&#x2013;e65. doi:10.1016/j.jpainsymman.2020.04.008, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2020.04.008</ArticleId><ArticleId IdType="pmc">PMC7151285</ArticleId><ArticleId IdType="pubmed">32283221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Wang H, Xie J, Zhang J, Li H, Liu S, et al. Burnout in ICU doctors and nurses in mainland China-A national cross-sectional study. J Crit Care 2021;62:265&#x2013;270. doi:10.1016/j.jcrc.2020.12.029, PMID: .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2020.12.029</ArticleId><ArticleId IdType="pubmed">33477093</ArticleId></ArticleIdList></Reference><Reference><Citation>Pressley T. Factors contributing to teacher burnout during COVID-19. Educational Researcher 2021;50(5):325&#x2013;327. doi:10.3102/0013189X211004138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3102/0013189X211004138</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;ld&#x131;r&#x131;m M, Solmaz F. COVID-19 burnout, COVID-19 stress and resilience: Initial psychometric properties of COVID-19 Burnout Scale. Death Stud 2022;46(3):524&#x2013;532. doi:10.1080/07481187.2020.1818885, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07481187.2020.1818885</ArticleId><ArticleId IdType="pubmed">32915702</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilar S, Isom DG. One Year of SARS-CoV-2: How Much Has the Virus Changed? Biology (Basel) 2021;10(2):91. doi:10.3390/biology10020091, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10020091</ArticleId><ArticleId IdType="pmc">PMC7911924</ArticleId><ArticleId IdType="pubmed">33530355</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Variant Proportion. Available from: https://covid.cdc.gov/covid-data-tracker/#variant-proportions.
Accessed January 16, 2023.</Citation></Reference><Reference><Citation>Callaway E. Coronavirus variant XBB.1.5 rises in the United States - is it a global threat? Nature 2023;613(7943):222&#x2013;223. doi:10.1038/d41586-023-00014-3, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-00014-3</ArticleId><ArticleId IdType="pubmed">36624320</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X, Xu J, Hussain S, Wang H, Gao N, Zhang L. Trends and Prediction in Daily New Cases and Deaths of COVID-19 in the United States: An Internet Search-Interest Based Model. Explor Res Hypothesis Med 2020;5(2):1&#x2013;6. doi:10.14218/ERHM.2020.00023, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/ERHM.2020.00023</ArticleId><ArticleId IdType="pmc">PMC7176069</ArticleId><ArticleId IdType="pubmed">32348380</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Shaikh M, Hauck K, Miraldo M. Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States. Proc Natl Acad Sci U S A 2021;118(12):e2021359118. doi:10.1073/pnas.2021359118, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2021359118</ArticleId><ArticleId IdType="pmc">PMC8000285</ArticleId><ArticleId IdType="pubmed">33658331</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr 2021;15(3):869&#x2013;875. doi:10.1016/j.dsx.2021.04.007, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ 2021;374:n1648. doi:10.1136/bmj.n1648, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbara JM, Gatt J, Xuereb RA, Tabone Adami N, Darmanin J, Erasmi R, et al. Clinical outcomes at medium-term follow-up of COVID-19. J R Coll Physicians Edinb 2022;52(3):220&#x2013;227. doi:10.1177/14782715221124617, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14782715221124617</ArticleId><ArticleId IdType="pmc">PMC9478632</ArticleId><ArticleId IdType="pubmed">36369815</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Fiore Bavaro D, Bonica R, et al. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med 2022;doi:10.1007/s11739-022-03164-w, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2022;19(23):16010. doi:10.3390/ijerph192316010, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine 2022;53:101624. doi:10.1016/j.eclinm.2022.101624, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson RM, Vegvari C, Truscott J, Collyer BS. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. Lancet 2020;396(10263):1614&#x2013;1616. doi:10.1016/s0140-6736(20)32318-7, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)32318-7</ArticleId><ArticleId IdType="pmc">PMC7836302</ArticleId><ArticleId IdType="pubmed">33159850</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Zhang L. Meet the challenges of mass vaccination against COVID-19. Explor Res Hypothesis Med 2021;6(2):77&#x2013;79. doi:10.14218/ERHM.2020.00075.</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/ERHM.2020.00075</ArticleId></ArticleIdList></Reference><Reference><Citation>China Coronavirus Full Vaccination Rate. Available from: https://ycharts.com/indicators/china_coronavirus_full_vaccination_rate.
Accessed Janurary 17, 2023.</Citation></Reference><Reference><Citation>Mathieu E, Ritchie H, Rod&#xe9;s-Guirao L, Appel C, Giattino C, Hasell J, et al.
Coronavirus Pandemic (COVID-19). Available from: https://ourworldindata.org/covid-vaccinations?country=CHN.
Accessed Janurary 17, 2023.</Citation></Reference><Reference><Citation>Baraniuk C. What do we know about China&#x2019;s covid-19 vaccines? BMJ 2021;373:n912. doi:10.1136/bmj.n912, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n912</ArticleId><ArticleId IdType="pubmed">33836994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 2022;399(10323):437&#x2013;446. doi:10.1016/S0140-6736(22)00017-4, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00017-4</ArticleId><ArticleId IdType="pmc">PMC8769664</ArticleId><ArticleId IdType="pubmed">35065011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulloa AC, Buchan SA, Daneman N, Brown KA. Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada. JAMA 2022;327(13):1286&#x2013;1288. doi:10.1001/jama.2022.2274, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.2274</ArticleId><ArticleId IdType="pmc">PMC8855311</ArticleId><ArticleId IdType="pubmed">35175280</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 2022;602(7898):671&#x2013;675. doi:10.1038/s41586-021-04389-z, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04389-z</ArticleId><ArticleId IdType="pubmed">35016199</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu S. Instant View: China&#x2019;s economy slows sharply in Q4, 2022 growth one of the worst on record. Available from: https://www.reuters.com/world/china/view-chinas-q4-growth-slows-29-yy-beats-expectations-2023-01-17/.
Accessed Janurary 16, 2023.</Citation></Reference><Reference><Citation>Douglas J. China&#x2019;s Economic Growth Fell to Near-Historic Lows as Covid Took a Bite. Available from: https://www.wsj.com/articles/chinas-economic-growth-fell-to-near-historic-lows-as-covid-took-a-bite-11673921199.
Accessed Janurary 17, 2023.</Citation></Reference><Reference><Citation>Zhang C, Xiao D, Zhou J, Zipser D. Survey: Chinese consumer sentiment during the coronavirus crisis. Available from: https://www.mckinsey.com/capabilities/growth-marketing-and-sales/our-insights/survey-chinese-consumer-sentiment-during-the-coronavirus-crisis.
Accessed February 28, 2023.</Citation></Reference><Reference><Citation>The World Bank. Fertility rate, total (births per woman) &#x2013; China. Available from: https://data.worldbank.org/indicator/SP.DYN.TFRT.IN?end= 2020&amp;locations=CN&amp;start=1980&amp;view=chart.
Accessed Janurary 16, 2023.</Citation></Reference><Reference><Citation>Master F, Zhang A. China to discourage abortions to boost low birth rate. Available from: https://www.reuters.com/world/china/china-discourage-abortions-boost-low-birth-rate-2022-08-16/.
Accessed February 01, 2023.</Citation></Reference><Reference><Citation>Sliver L, Huang C. Key facts about China&#x2019;s declining population. Available from: https://www.pewresearch.org/fact-tank/2022/12/05/key-facts-about-chinas-declining-population/.
Accessed Janurary 15, 2023.</Citation></Reference><Reference><Citation>Aassve A, Cavalli N, Mencarini L, Plach S, Livi Bacci M. The COVID-19 pandemic and human fertility. Science 2020;369(6502):370&#x2013;371. doi:10.1126/science.abc9520, PMID:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc9520</ArticleId><ArticleId IdType="pubmed">32703862</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>